Hallura
Yoqne`am `illit
About Hallura
Hallura is a biotechnology company for natural and soft aesthetic treatments. The company developing a new generation of Hyaluronic Acid (HA) Dermal Fillers and intends to use the funds to complete its clinical trials and register its proprietary Hyaluronic Acid Dermal Fillers in Europe. Hallura aims to build a new technology platform in order to create the next generation of dermal fillers for aesthetic medicine and overcome the limitations of current products. The company was founded in November 2017 and is based in Yoqneam, Israel.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2019)
- Website: hallura.com
- Phone: +972 4 8550240
Industries & Categories
Biotechnology, Clinical Trials, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/hallura-110266 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.